Enhanced or reversible RNA N6-methyladenosine editing by red/far-red light induction
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Heng Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 4…. Hauptthemen laut MEDLINE: Adenosine, RNA Editing, Light, Gene Editing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and Technology, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The RNA N6-methyladenosine (m6A) modification is a critical regulator of various biological processes, but precise and dynamic control of m6A remains a challenge. In this work, we present a red/far-red light-inducible m6A editing system that enables efficient and reversible modulation of m6A levels with minimal off-target effects. By engineering the CRISPR dCas13 protein and sgRNA with two pairs of light-inducible heterodimerizing proteins, ΔphyA/FHY1 and Bphp1/PspR2, we achieved targeted recruitment of m6A effectors. This system significantly enhances m6A writing efficiency and allows dynamic regulation of m6A deposition and removal on specific transcripts, such as SOX2 and ACTB. Notably, reversible m6A editing was achieved through cyclic modulation at a single target site, demonstrating the ability to influence mRNA expression and modulate the differentiation state of human embryonic stem cells. This optogenetic platform offers a precise, versatile tool for cyclic and reversible m6A regulation, with broad implications for understanding RNA biology and its potential applications in research and medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430072, China.
- College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University, Wuhan 430072, P.R. China.
- Department of Biological Repositories, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
- State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan 430062, China.
- Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
- Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei 430072, P.R. China.
ORCID-Profile: Xiang Zhou, Wei Jiang, Xiaocheng Weng
Förderung
- Ministry of Science and Technology
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Tang, H., Han, S., Jie, Y., Jiang, X., Zhang, Y., Peng, J., Wang, F., Li, X., Zhou, X., Jiang, W., & Weng, X. (2025). Enhanced or reversible RNA N6-methyladenosine editing by red/far-red light induction. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf181
Vancouver
Tang H, Han S, Jie Y, Jiang X, Zhang Y, Peng J, et al. Enhanced or reversible RNA N6-methyladenosine editing by red/far-red light induction. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf181
BibTeX
@article{Tang2025,
author = {Tang, Heng and Han, Shaoqin and Jie, Yang and Jiang, Xin and Zhang, Yi and Peng, Junran and Wang, Fang and Li, Xiang and Zhou, Xiang and Jiang, Wei and Weng, Xiaocheng},
title = {Enhanced or reversible RNA N6-methyladenosine editing by red/far-red light induction},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf181}
}
EUVIMED